Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal
Clinical trial NCT05256732 · COMPLETED
Trial details
- NCT number
- NCT05256732
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2022-08-23
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.